POINT Biopharma Provides Updated Efficacy and Safety Data
Newly published poster on the single-arm 27-patient safety and dosimetry lead-in provides key updates including: A median rPFS time of 11.5 months A...
Stay updated with breaking news from Aaronr Hansen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Newly published poster on the single-arm 27-patient safety and dosimetry lead-in provides key updates including: A median rPFS time of 11.5 months A...
INDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. PNT (the "Company" or "POINT"), a company accelerating the discovery, dev
Poster #1400P will be presented on Sunday, September 11 by Dr. Aaron R. ...
05.09.2022 - Poster #1400P will be presented on Sunday, September 11 by Dr. Aaron R. HansenINDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) - POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, ... Seite 1